前收市價 | 9.26 |
開市 | 9.36 |
買盤 | 9.06 x 1200 |
賣出價 | 9.63 x 800 |
今日波幅 | 8.95 - 9.42 |
52 週波幅 | 7.37 - 11.56 |
成交量 | |
平均成交量 | 426,137 |
市值 | 831.798M |
Beta 值 (5 年,每月) | 0.97 |
市盈率 (最近 12 個月) | 452.50 |
每股盈利 (最近 12 個月) | 0.02 |
業績公佈日 | 2024年8月06日 - 2024年8月12日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 9.96 |
While the top- and bottom-line numbers for Enfusion (ENFN) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Radware (RDWR) delivered earnings and revenue surprises of 14.29% and 2.34%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Discovering and allocating to undervalued stocks is a key element of successful investing. Stocks are considered “undervalued” when they trade below what people think their intrinsic value is. Basically, in this scenario, the market has not fully recognized the stock’s “true potential.” Potential value investors can find many stocks that are undervalued if they look for stocks trading below a certain dollar amount per share. In this list, in particular, we will be looking at the most undervalued